Lead Product(s) : Carbon Dioxide
Therapeutic Area : Neurology
Study Phase : Phase II
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Nasal Carbon Dioxide for the Symptomatic Treatment of Classical Trigeminal Neuralgia
Details : Carbon Dioxide is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Trigeminal Neuralgia.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
June 16, 2015
Lead Product(s) : Carbon Dioxide
Therapeutic Area : Neurology
Highest Development Status : Phase II
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Carbon Dioxide
Therapeutic Area : Neurology
Study Phase : Phase II
Sponsor : Capnia
Deal Size : Inapplicable
Deal Type : Inapplicable
Pilot Study Evaluating the Use of Nasal Carbon Dioxide for the Treatment of Cluster Headache
Details : Carbon Dioxide is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Cluster Headache.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
March 06, 2015
Lead Product(s) : Carbon Dioxide
Therapeutic Area : Neurology
Highest Development Status : Phase II
Sponsor : Capnia
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Carbon Dioxide
Therapeutic Area : Otolaryngology (Ear, Nose, Throat)
Study Phase : Phase II
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Market Potential of Carbon Dioxide Nasal Spray
Details : Carbon Dioxide is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Nasal Obstruction.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
April 14, 2014
Lead Product(s) : Carbon Dioxide
Therapeutic Area : Otolaryngology (Ear, Nose, Throat)
Highest Development Status : Phase II
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Carbon Dioxide
Therapeutic Area : Neurology
Study Phase : Phase II
Sponsor : Walter Reed National Military Medical Center | U.S. Naval Medical Center San Diego | U.S. Naval Medical Center Portsmouth | Madigan Army Medical Center
Deal Size : Inapplicable
Deal Type : Inapplicable
The Effect of Nasal Carbon Dioxide in the Treatment of Moderate to Severe Migraine
Details : Carbon Dioxide is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Migraine Disorders.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
December 06, 2010
Lead Product(s) : Carbon Dioxide
Therapeutic Area : Neurology
Highest Development Status : Phase II
Sponsor : Walter Reed National Military Medical Center | U.S. Naval Medical Center San Diego | U.S. Naval Medical Center Portsmouth | Madigan Army Medical Center
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
